Detecting knee cartilage thickness change at three and six months  by Buck, R. et al.
Figure 1. Odds ratio for Rapid Progression in ROA versus Asymptomatic
Cohorts after various adjustments to underlying variability in Asympto-
matic cohort.Black (open) ¼ Thinning, Blue (closed) ¼ Thickening, Red
(dashes) represents p ¼ 0.05 (approximately). square ¼ SD adjustment
equal for all regions, circle ¼ adjustments differ between central and
external regions and remaining regions.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S67organisation of the collagen network within the cartilage. We are thus
preparing methods to image this signal in vivo using FFC MRI and zero
echo time acquisition techniques. We hope applications of this tech-
nique will allow new ways to non-invasively detect and stage osteo-
arthritic cartilage before morphological structural changes occur, as are
appreciated with conventional MRI techniques.
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RELEASED MACROPHAGE MARKERS AS PREDICTORS OF KNEE OA
PROGRESSION
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Physiology, Durham, NC, USA; zDuke Univ. Med. Ctr., Durham, NC, USA
Purpose: Despite being one of themost common types of arthritis and a
leading cause of disability worldwide, Osteoarthritis (OA) often goes
undiagnosed until its later stages and little beyond palliative therapy is
available. Biomarkers are particularly needed that can be used for
prognosis or to monitor the efﬁcacy of future therapeutics. There are
many unanswered questions regarding the complex nature of joint tis-
sue biology, but the role of innate immunity in the pathology of OA has
becomemore evident in recent years. Speciﬁcally, synovialmacrophage-
produced cytokines drive aggrecanases, matrix metalloproteinases, and
other destructive responses towards cartilage degradation. Moreover,
the pattern of synovial ﬂuid (SF) cytokines in knee OA is indicative of
macrophage-mediated inﬂammasome activation. In a recent study, we
showed that the quantity of folate receptor (FR-bþ) macrophages in
joints based on etarfolatide imaging correlated with radiographic knee
OA. We also showed that sCD163 and sCD14, which are macrophage
markers, correlated with inﬂammatory phenotypes and radiographic
severity of OA. The goal of this study was to evaluate the effectiveness of
using the macrophage marker, sCD163, as a prognostic tool for knee OA.
Methods: sCD163 was measured by ELISA in the synovial ﬂuid of 86
subjects (128 knees) with knee OA from the Prediction of Osteoarthritis
Progression (POP) cohort. The POP cohort provided baseline SF and
serum samples and 3-year longitudinal follow-up to assess the pre-
dictive capability of sCD163 for radiographic OA structural progression
based on either osteophyte formation or joint space narrowing. Models,
using generalized estimating equations (to account for correlation
within knees), were ﬁtted with adjustment for age, gender, and body
mass index (BMI), to evaluate associations of sCD163 with OA pro-
gression phenotypes. P values 0.05 were considered signiﬁcant.
Results: Baselinesynovialﬂuid sCD163wasassociatedwithprogressionof
kneeOA; speciﬁcally SF sCD163was associatedwith change in osteophyte
severity (p ¼ 0.0107), but not change in joint space narrowing. However,
systemic sCD163 did not show any correlation with OA progression.
Conclusions: Shedding of CD163 from macrophages typically occurs in
response to oxidative stress mediators and other inﬂammatory stimuli.
The association of SF sCD163 with knee OA progression supports the
growing inference that inﬂammation plays an important role in the
progression of disease; this marker could prove useful for identifying a
high-risk subgroup of knee OA patients. Furthermore, these results
contribute to a growing literature identifying macrophages and mac-
rophage-activation pathways as potential targets for new OA therapies.
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DETECTING KNEE CARTILAGE THICKNESS CHANGE AT THREE AND
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Purpose: Previous work found large differences (> 10%/y and < -10%/y)
in knee cartilage thickness in distinct subregions of the joint between
annual visits and these were more frequent in osteoarthritis patients
than in asymptomatic subjects. Given these large observed changes in
as little as 12 months, it is likely that important changes in cartilage
thickness may be detectable at even shorter intervals. The goal of this
study is to explore the magnitude of femorotibial cartilage thickness
changes in participants with radiographic osteoarthritis (ROA) and
asymptomatic subjects over three and six month observation periods.
Data are available at 12 and 24month periods for the same subjects and
make it possible, for the ﬁrst time, to directly compare short, i.e., 3month, versus long-term, i.e., 24 month, changes. We also present
robustness studies to assess the potential impact of observed, but
statistically insigniﬁcant, differences between ROA and asymptomatic
knees in the measurement error of cartilage thickness change.
Methods: CoronalMR images (3 Tesla) were acquired in 145women (71
with ROA, 74 without symptoms or ROA) at baseline, 3, 6, 12 and 24
months. Femorotibial cartilage thickness was determined for ﬁve tibial
and three femoral subregions in each (medial/lateral) compartment at
each visit. Rapid change in knee cartilage in individual regions was
classiﬁed via false discovery methods and the frequencies of rapid
change were compared between ROA and asymptomatic subjects.
Ordered values of knee regional cartilage thickness change in ROA and
asymptomatic cohorts were also compared. Differences between ROA
and asymptomatic subjects in measurement error, as estimated from
scan/rescan analyses, were not statistically signiﬁcant, but standard
deviations were slightly higher (average of 10%) in ROA subjects. To
assess possible differences in variability between the ROA and asymp-
tomatic knees, thickness change in asymptomatic subjects were nor-
malized by a) increasing change values by up to 60% across all regions;
or b) increasing change values by up to 60% in central and external
regions, while increasing change values in remaining regions by 5%.
Results: Rapid cartilage thinning was found in 18.3% of ROA subjects at
Month 3 and this increased steadily over time with 25.4%, 33.8%, and
40.8% at Months 6,12, and 24. These frequencies were higher (p-value<
0.05) than observed in the asymptomatic cohort at all visits except
Month 3. In contrast, The percentage of subjects in the ROA cohort with
rapid cartilage thickening was also statistically larger than frequencies
observed in the asymptomatic cohort, but were 28.2%, 21.1% and 33.8%
for Months 3, 6, and 12 and dropped to only 7% at Month 24 showing no
apparent trend over time. Even after inﬂating asymptomatic change by
15 to 45% the frequency of rapid progression was still signiﬁcantly
higher in ROA cohort than in asymptomatic cohort, except at Month 3;
see ﬁgure. While the largest percentage of subjects with rapid pro-
gression (thinning or thickening) at a given visit was 59%, overall the
percentage of subjects with rapid progression at some visit was 81.7%.
Also, although less than 8% of regions were classiﬁed as having rapid
progression they accounted for 34% (at Month 3) to 64% (at Month 24)
of observed variation from zero in thickness change. Results from
ordered values were similar, but not as robust to adjusting standard
deviation.
Conclusions: Regions with rapid subregional (focal) progression are an
important component of cartilage thickness change in subjects with
osteoarthritis. This study reafﬁrms the method used for classiﬁcation is
reasonable for estimating rapid progression in an ROA cohort. The
results show that rapid thinning and thickening is detectable at six
months and may also be present at three months.
